gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
TILs recognize tumor-derived peptide–HLA class II via native TCRs and kill the presenting cell through cytotoxic effector functions (perforin/granzyme and/or Fas–FasL).
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
CD4+ TCR recognition of peptide–HLA-DR/DP/DQ complexes on tumor or antigen-presenting cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06541327
disease_id_num_tar_ref
5328
drug_id_num_tar_ref
14505